The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

FILE - A doctor uses a hand-held Doppler probe on a pregnant woman to measure the heartbeat of the fetus, Dec. 17, 2021, in Jackson, Miss. (AP Photo/Rogelio V. Solis, File) From Philly and the Pa.

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA released draft guidance in January 2026 encouraging the use of Bayesian statistics in clinical trials, a shift that could ...

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to ...